Lipodox

Type: Product

Name: Lipodox

First reported May 20 2013 - Updated May 20 2013 - 1 reports

SUNPHARMA - Acquisitions to Drive the Next Growth Wave - new market research report

Sun Pharma's Q3 FY13 result was better than our estimates largely on account of stronger sales of Taro. Lipodox continued during the quarter. We expect sustainable annual sales of $80-100m for Sun's Lipodox, assuming entry of one additional generic player ... [Published TransWorldNews - May 20 2013]

Entities: Acquisition, Sun Pharmaceutical Industries Ltd, Lipodox

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Dr Reddy's Laboratories Ltd

Sun Pharma's bigger than three rivals put together

MUMBAI: The stock of Sun Pharmaceuticals hit a record high on Tuesday, catapulting its market capitalisation above that of Dr Reddy's Laboratories, Cipla and Lupin put together. An impressive revenue and profit growth, benefits from overseas acquisitions, ... [Published Economic Times - May 07 2013]

Entities: Sun Pharmaceutical Industries Ltd, URL Pharma Inc, Dr Reddy's Laboratories Ltd, Cipla Ltd

First reported Feb 04 2013 - Updated Feb 05 2013 - 1 reports

Generic Doxil: FDA Approves Non-Brand-Name Version Of Cancer Drug

* FDA approves Sun Pharma Global FZE's generic Doxil * First generic version to be approved by FDA* Approval expected to relieve shortagesBy Toni ClarkeFeb 4 (Reuters) - U.S. health regulators have approved a generic version of the cancer drug Doxil ... [Published The Huffington Post | Full News Feed - Feb 04 2013]

Entities: Doxil, Sun Pharmaceutical Industries Ltd, Generic Version, Lipodox

Quotes

"Sun has run up a lot over the last few weeks. The stock could correct 5-10%, which we would view as a good opportunity to add to positions in India's best generic company (world's second-largest by market cap after Teva)" said Morgan Stanley in a report on Monday

Sun Pharma's bigger than three rivals put together [Published Economic Times - May 07 2013]

More Content

sort by: Date \| Relevance
SUNPHARMA - Acquisitions to Drive the Next Grow... [Published TransWorldNews - May 20 2013]
Sun Pharma's bigger than three rivals put together [Published Economic Times - May 07 2013]
Sun Pharmaceuticals' stock hit a record high [Published Economic Times - May 07 2013]
EGEN, Inc. Announces a Phase I Clinical Trial f... [Published PR Newswire: Health - Mar 19 2013]
Sun Pharma net profit jumps by 32% to Rs.881 cr... [Published PharmaBiz - Feb 08 2013]
Generic Doxil: FDA Approves Non-Brand-Name Vers... [Published The Huffington Post \| Full News Feed - Feb 04 2013]
Sun Pharma net dips to Rs.320 cr on Protonix li... [Published PharmaBiz - Nov 08 2012]